CymitQuimica logo

Rituximab - 20mg/ml solution

CAS:

Ref. 3D-FR138503

ne
To inquire
Rituximab - 20mg/ml solution
Biosynth

Product Information

Name:Rituximab - 20mg/ml solution
Brand:Biosynth
Description:Rituximab is a glycosylated monoclonal antibody that binds to the CD20 cell surface protein which is widely expressed on B-cells. Through the binding of rituximab’s Fc portion, the antibody-dependent cellular cytotoxicity pathway (ADCC) and the complement-dependent cytotoxicity (CDC) pathway are initiated, both leading to B-cell lysis (Chisari, 2021). In addition, direct apoptosis can be the result of the inhibition of various B-cell signalling pathways. Rituximab is used in targeted therapy for chronic lymphocytic leukaemia (CLL), non-Hodgkin lymphoma (NHL) and some non-cancer pathologies, such as, multiple sclerosis (Johnson, 2001).
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:143769.11977
Formula:C6416H9874N1688O1987S44
Purity:Min. 95%
Color/Form:Powder

Technical inquiry about: Rituximab - 20mg/ml solution

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.